These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3458003)

  • 21. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE; Johnson CA
    Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminum bone disease. (A case study).
    Coleman S
    J Nephrol Nurs; 1985; 2(3):125-6. PubMed ID: 3848476
    [No Abstract]   [Full Text] [Related]  

  • 23. Aluminum and renal osteodystrophy.
    Nebeker HG; Coburn JW
    Annu Rev Med; 1986; 37():79-95. PubMed ID: 3085581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Sprague SM; Corwin HL; Wilson RS; Mayor GH; Tanner CM
    Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
    Tielemans C; Collart F; Wens R; Smeyers-Verbeeke J; van Hooff I; Dratwa M; Verbeelen D
    Clin Nephrol; 1985 Nov; 24(5):237-41. PubMed ID: 4075595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of aluminum on bone and cell localization.
    Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S
    Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993
    [No Abstract]   [Full Text] [Related]  

  • 27. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
    Rapoport J; Chaimovitz C; Abulfil A; Mostovlavsky M; Gazit D; Bab I
    Isr J Med Sci; 1987 Dec; 23(12):1242-6. PubMed ID: 3440748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease.
    Sherrard DJ; Walker JV; Boykin JL
    Am J Kidney Dis; 1988 Aug; 12(2):126-30. PubMed ID: 3400633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sporadic aluminum osteomalacia: identification of patients at risk.
    Turner MW; Ardila M; Hutchinson T; Prichard S; Barré PE; Beauvais J; Kaye M
    Am J Kidney Dis; 1988 Jan; 11(1):51-6. PubMed ID: 3337100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of aluminium toxicity in a 'low incidence' area.
    Winney RJ; Cowie JF; Cumming AD; Short AI; Smith GD; Robson JS
    Contrib Nephrol; 1984; 38():47-58. PubMed ID: 6713900
    [No Abstract]   [Full Text] [Related]  

  • 31. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.
    Felsenfeld AJ; Rodriguez M; Coleman M; Ross D; Llach F
    Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
    Mudde AH; Roodvoets AP; Van Groningen K
    Neth J Med; 1985; 28(1):6-11. PubMed ID: 3974771
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombocytopenia associated with intravenous desferrioxamine.
    Walker JA; Sherman RA; Eisinger RP
    Am J Kidney Dis; 1985 Oct; 6(4):254-6. PubMed ID: 4050784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.
    Felsenfeld AJ
    ANNA J; 1985 Jun; 12(3):189-91. PubMed ID: 3848318
    [No Abstract]   [Full Text] [Related]  

  • 37. The bone scan in patients with aluminium-associated bone disease.
    Botella J; Gallego JL; Fernandez-Fernandez J; Sanz-Guajardo D; de Miguel A; Ramos J; Franco P; Enriques R; Sanz-Moreno C
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():403-9. PubMed ID: 3991532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
    Wills MR; Savory J
    Lancet; 1983 Jul; 2(8340):29-34. PubMed ID: 6134894
    [No Abstract]   [Full Text] [Related]  

  • 39. [Successful treatment of progressive dialysis encephalopathy. Case report].
    Weiland P; Köhler M; Glatzel E
    Z Urol Nephrol; 1985 Jul; 78(7):387-93. PubMed ID: 4050157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment and histological healing of aluminum-related osteomalacia.
    Boyce BF; Mocan MZ; Byars J; Junor BJ
    Contrib Nephrol; 1988; 64():151-9. PubMed ID: 3180822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.